The annual J.P. Morgan Healthcare Conference, often called the Superbowl of biotech, kicked off on Jan. 8, 2018.
Over 450 companies will be presenting, including Celgene (CELG), Pfizer (PFE 0.42%), and Johnson & Johnson (JNJ 0.89%), and over 9,000 people (including The Motley Fool's Kristine Harjes) will be attending. But don't worry -- The Motley Fool's healthcare team will keep you informed about the most important announcements and analysis. Check back daily for updates!
- Why Exact Sciences Is Tumbling Today
- 5 Things You Need to Know From Celgene's J.P. Morgan Presentation
- The 1 Word That Explains Why Pfizer's Future Looks Brighter Than Its Past
- 10 Things to Expect From Vertex Pharmaceuticals in 2018
- Johnson & Johnson Wants to Create a Crisis -- and That's Great for Investors
PS -- if you're interested in checking out how much things have changed since this time in 2017, here's last year's landing page.